Envision Healthcare, once the largest emergency medicine staffing company in the United States, has completed its second bankruptcy reorganization and sold its remaining emergency department staffing contracts to a consortium of regional physician groups. The sale marks the effective end of Envision as a national EM staffing entity and closes a chapter in the private equity takeover of emergency medicine that began in 2011.
The story of Envision Healthcare is, in many ways, the story of private equity in emergency medicine — a cautionary tale of financial engineering applied to a sector where the consequences of failure are measured not in shareholder value but in patient care. The company's second bankruptcy and dissolution as a national entity represents the culmination of a 15-year experiment that reshaped emergency medicine staffing and, according to its critics, degraded the quality of care in hundreds of emergency departments across the country.
Envision Healthcare's origins trace to Emergency Medical Services Corporation (EMSC), a publicly traded emergency medicine staffing company that was taken private by private equity firm Clayton, Dubilier & Rice in 2011 for approximately $3.2 billion. The company subsequently merged with AmSurg Corporation in 2016 to form Envision Healthcare, creating an entity that at its peak staffed emergency departments, anesthesiology departments, and surgical facilities at more than 900 hospitals across 45 states.
In 2018, KKR & Co. acquired Envision in a leveraged buyout valued at approximately $9.9 billion — one of the largest private equity transactions in healthcare history. The deal loaded Envision with approximately $7 billion in debt, a burden that would prove fatal when the company's business model encountered the twin shocks of the COVID-19 pandemic and the No Surprises Act.
To understand Envision's collapse, it is necessary to understand how the company generated revenue. Envision's emergency medicine staffing model relied heavily on out-of-network billing — the practice of staffing hospital emergency departments with physicians who were not in the insurance networks of the patients they treated, then billing those patients at rates far above what insurers would pay in-network.
This practice, which critics characterized as exploitative and which generated thousands of patient complaints, was legal until the No Surprises Act took effect in January 2022. Under the NSA, out-of-network emergency providers are limited to collecting in-network cost-sharing from patients, and disputes about payment rates are resolved through an independent arbitration process rather than through direct patient billing.
The No Surprises Act effectively eliminated the out-of-network billing revenue stream that had been a significant component of Envision's financial model. The company had anticipated this regulatory change and had been attempting to negotiate in-network contracts with major insurers, but the transition proved more difficult and less financially favorable than management had projected.
Envision filed for Chapter 11 bankruptcy protection in May 2023, listing approximately $7.7 billion in liabilities. The filing cited the No Surprises Act's impact on revenue, the lingering effects of COVID-19 on procedure volumes, and the company's unsustainable debt load as primary causes. KKR, which had invested approximately $3.5 billion in equity in the 2018 transaction, received essentially nothing in the reorganization.
The first bankruptcy reorganization, completed in December 2023, reduced Envision's debt from $7.7 billion to approximately $1.4 billion and transferred ownership to a group of former creditors. The reorganized company retained approximately 400 hospital staffing contracts, down from a peak of more than 900, and shed its anesthesiology and surgical facility businesses.
The reorganized Envision proved unable to achieve financial stability. The company filed for Chapter 11 a second time in September 2025, citing continued revenue pressure from the No Surprises Act's independent dispute resolution process — which had been producing payment rates significantly below Envision's cost structure — and ongoing physician recruitment and retention challenges driven by the company's reputation and compensation structure.
The second bankruptcy process, completed in April 2026, resulted in the sale of Envision's remaining emergency medicine staffing contracts to a consortium of regional physician groups organized by a healthcare investment firm. The sale was structured as a series of individual contract assignments rather than a single transaction, with different regional groups acquiring contracts in their respective geographic markets.
The acquiring groups include several physician-owned emergency medicine organizations that have been critical of the private equity staffing model, as well as several hospital-employed physician groups that are absorbing former Envision contracts as part of broader hospital employment strategies. The transactions are expected to close on a rolling basis through the third quarter of 2026.
The dissolution of Envision as a national entity has created significant uncertainty for the approximately 11,000 physicians and advanced practice providers who were employed by the company at the time of the second bankruptcy filing. Most will transition to employment with the acquiring regional groups, but the terms of those transitions — compensation, benefits, scheduling, and governance — vary significantly across the different acquiring organizations.
Emergency medicine physician advocacy organizations have expressed cautious optimism about the transition to regional and physician-owned groups, arguing that these organizations are more likely to prioritize physician input into clinical operations and less likely to impose the productivity metrics and administrative burdens that characterized employment under Envision. Several physician groups have reported that former Envision physicians are accepting compensation reductions in exchange for improved working conditions and greater professional autonomy.
For patients, the transition is expected to be largely transparent — the same physicians will continue working in the same emergency departments, under new organizational arrangements. The primary patient-facing change will be in billing: the acquiring groups have committed to maintaining in-network contracts with major insurers, eliminating the out-of-network billing that generated patient complaints under Envision's model.
Envision's collapse is the most dramatic example of a broader pattern of private equity distress in emergency medicine staffing. TeamHealth, the other major PE-backed EM staffing company, has also faced significant financial pressure from the No Surprises Act and has been restructuring its operations, though it has not filed for bankruptcy. Several smaller PE-backed EM staffing companies have been acquired or dissolved in the past three years.
Academic researchers who have studied the private equity model in emergency medicine argue that the Envision story illustrates a fundamental incompatibility between the financial engineering approach of leveraged buyouts and the operational realities of emergency medicine staffing. The business model depended on revenue streams — primarily out-of-network billing — that were ethically questionable and ultimately legally prohibited. When those revenue streams were eliminated, the underlying business could not generate sufficient returns to service the debt load imposed by the leveraged buyout structure.
Whether the lesson will deter future private equity investment in emergency medicine staffing remains to be seen. Several PE firms have expressed interest in acquiring the regional groups that are absorbing Envision's contracts, suggesting that the appetite for investment in EM staffing has not been extinguished — only redirected toward models that are compatible with the post-No Surprises Act regulatory environment.
ER Times will continue tracking the transition of former Envision contracts and the broader evolution of emergency medicine staffing models. Our investigative series on private equity in emergency medicine is available in the Investigative section.
ER Times tracks private equity in healthcare, staffing industry consolidation, and financial accountability.